Clinical Trials Browser

Phase 2 × Neuroma, Acoustic × 1 year × Clear all

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT03079999 2025-12-18

Study of Aspirin in Patients With Vestibular Schwannoma

Phase 2 Active not recruiting

97 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Phase 2 Completed

50 enrolled

CNS

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT03095248 2025-04-22

SEL-TH-1601

Phase 2 Terminated

10 enrolled 9 charts

CNS

Ependymoma, Glioma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Clinical Trials

INTUITT-NF2

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Study of Aspirin in Patients With Vestibular Schwannoma

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

SEL-TH-1601